Pharming Group N.V. - ADR (PHAR) Stock Price

11.72 ▼ -0.63 (-5.10%)
Open: 11.94 Vol: 20.4K Day's range: 11.6672 - 12.5083 Aug 14, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PHAR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.28▼ 12.34▼ 12.14▼ 11.90▼ 11.77▼
MA10 12.21▼ 12.07▼ 11.80▼ 11.20▲ 12.55▼
MA20 11.68▲ 11.36▲ 11.08▲ 11.79▼ 13.71▼
MA50 11.73▲ 12.28▼ 12.37▼ 12.66▼ 15.19▼
MA100 12.51▼ 12.78▼ 13.47▼ 13.97▼ 12.34▼
MA200 13.95▼ 14.41▼ 14.72▼ 15.33▼ 11.74▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.071▲ 0.167▲ 0.215▲ 0.147▲ -0.252▼
RSI 50.782▲ 49.582▼ 49.505▼ 46.891▼ 40.688▼
STOCH 60.137     72.211     76.333     65.915     39.613    
WILL %R -73.507     -46.462     -36.280     -43.360     -57.606    
CCI -47.096     2.032     36.342     57.295     -77.087    
Latest Filters Detected On PHAR
RSI $PHAR RSI(14) Crossed Below 50 Set Alert
MA $PHAR Price Crossed Below MA(26) Set Alert
▼ GAP $PHAR Open Gap Down %3 Set Alert
▼ GAP $PHAR Open Gap Down %2 Set Alert
Pharming Group N.V. - ADR News
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Friday, August 14, 2026 11:53 AM
VRTX) announced a strategic collaboration to research, develop, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases. Under the agreement, AbCellera will leverage its ...
Winners and losers of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) vs the rest of the generic pharmaceuticals stocks
Wednesday, August 12, 2026 08:32 PM
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ANI Pharmaceuticals (NASDAQ:ANIP) and the ...
Pfizer (NYSE:PFE) Draws Value-Focused Attention As Pharma Steadies Amid Caution
Wednesday, August 12, 2026 02:29 PM
Pricing and reimbursement conditions can also influence pharmaceutical performance as governments, healthcare systems, and insurers assess treatment costs and clinical value. Patent expirations create ...
PHAR historical stock data
date open high low close volume
14/08/26 11.94 12.5083 11.6672 11.72 20,403
13/08/26 12.06 13.32 11.80 12.35 32,740
12/08/26 11.81 12.1302 11.66 11.83 38,277
11/08/26 11.46 12.33 11.31 12.23 89,766
10/08/26 10.82 11.7158 10.5377 11.35 60,766
07/08/26 11.08 11.15 10.89 10.95 6,136
06/08/26 10.76 10.99 10.715 10.85 3,522
05/08/26 10.66 10.8492 10.54 10.675 5,277
04/08/26 10.40 10.5505 10.01 10.26 10,357
03/08/26 10.13 10.185 9.81 9.82 33,874
Quote Details
52wk Low:9.63
52wk High:21.34
Vol:20.4K
Avg Vol(3m):212.6K
1Y Chng:-16.35%
1M Chng:-18.10%
Add to Watch List
More Information
Index US Composite
Market Cap. 874.11M